首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia
Authors:Tomohiro Oishi  Mitsuo Narita  Kou Matsui  Takahiro Shirai  Mai Matsuo  Jun Negishi  Takayuki Kaneko  Shinya Tsukano  Tetsuo Taguchi  Makoto Uchiyama
Affiliation:(1) Division of Pediatrics, Department of Homeostatic Regulation and Development, Niigata University Graduate School of Medicine and Dental Sciences, Asahimachi, Niigata 951-8510, Japan;(2) Department of Pediatrics, Niigata Prefectural Shibata Hospital, 1-2-8 Honcho, Shibata, Niigata 957-8588, Japan;(3) Department of Pediatrics, Sapporo Tokushukai Hospital, Sakae-dori 18-4-10, Shiroishi-ku, Sapporo 003-0021, Japan
Abstract:The immunological pathogenesis of Mycoplasma pneumoniae pneumonia is known to involve several cytokines. The serum levels of interleukin-18 (IL-18) were examined using enzyme-linked immunosorbent assay in 23 pediatric patients (median age 6 years; range 4–13 years; 14 girls and 9 boys) with M. pneumoniae pneumonia admitted to our hospital. Serum levels of IL-18 ranged from 22 to 1808 pg/ml with a mean of 543 pg/ml. We started steroid therapy in two cases with IL-18 values greater than 1000 pg/ml without being aware of IL-18 levels. Examination of associations between IL-18 levels determined by enzyme-linked immunosorbent assay and a routine laboratory test showed that levels of lactate dehydrogenase (LDH) and IL-18 were significantly correlated. To determine the appropriateness of steroid administration in M. pneumoniae pneumonia patients, serum LDH should be examined. Patients with elevated levels of LDH are likely to have significantly elevated IL-18 values (≥1000 pg/ml) and thus can be candidates for steroid therapy.
Keywords:Interleukin-18 (IL-18)  Lactate dehydrogenase (LDH)  Child  Pneumonia
本文献已被 ScienceDirect SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号